AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31982649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30621791 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMhi Stay Strong App
Number of subjects: 0
Study 30621791 — intervention group
Group type: COMPARATOR
Intervention: Control app intervention
Number of subjects: 0
Study 30621791 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 28712490 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (1.5mg/kg/day, max 50mg/day)
Number of subjects: 0
Study 28712490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26823335 — intervention group
Group type: COMPARATOR
Intervention: HRV administered at 6 and 10 weeks (group 1)
Number of subjects: 456
Study 26823335 — intervention group
Group type: COMPARATOR
Intervention: HRV administered at 10 and 14 weeks (group 2)
Number of subjects: 456
Study 26823335 — intervention group
Group type: COMPARATOR
Intervention: HRV administered at 6, 10, and 14 weeks (group 3)
Number of subjects: 456
Study 24668767 — intervention group
Group type: EXPERIMENTAL
Intervention: Kripalu-based yoga intervention
Number of subjects: 38
Study 24668767 — intervention group
Group type: COMPARATOR
Intervention: Assessment control group
Number of subjects: 38
Study 22781186 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (500 mg capsules of ginger root powder, three times a day)
Number of subjects: 120
Study 22781186 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mg capsules, three times a day)
Number of subjects: 120
Study 19038375 — intervention group
Group type: EXPERIMENTAL
Intervention: 350‐mm(2) Baerveldt glaucoma implant (tube group)
Number of subjects: 55
Study 19038375 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC) (trabeculectomy group)
Number of subjects: 55
Study 17549745 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside procedure service offered to physicians from 1 of 3 firms for 4 weeks
Number of subjects: 1941
Study 17549745 — intervention group
Group type: COMPARATOR
Intervention: Control group (firms not offered the bedside procedure service)
Number of subjects: 1941
Study 17549745 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside procedure service
Number of subjects: 1941
Study 15659722 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 2521
Study 15659722 — intervention group
Group type: COMPARATOR
Intervention: ICD therapy
Number of subjects: 2521
Study 15659722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2521
Study 11926711 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) plus standard medical therapy (ST)
Number of subjects: 34
Study 11926711 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (ST) alone
Number of subjects: 34
Study 9524991 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice group (male latex condoms and nonoxynol‐9 film)
Number of subjects: 167
Study 9524991 — intervention group
Group type: COMPARATOR
Intervention: Condom group (male latex condoms only)
Number of subjects: 167
Study 8088297 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-regurgitation formula with thickening product, positional treatment, parental reassurance
Number of subjects: 20
Study 8088297 — intervention group
Group type: COMPARATOR
Intervention: placebo (same formula without thickening product, positional treatment, parental reassurance)
Number of subjects: 20
Study 2764265 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaglobin (10 g daily on the 3rd, 4th, and 5th day)
Number of subjects: 50
Study 2764265 — intervention group
Group type: COMPARATOR
Intervention: Human albumin (12.5 g daily on the 3rd, 4th, and 5th day)
Number of subjects: 50
Study 29986444 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - participated in the MHL promotion program (two sessions, 90 min each) delivered at one-week intervals.
Number of subjects: 543
Study 29986444 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - did not participate in the MHL promotion program.
Number of subjects: 543
Study 27606566 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamelon® Preventive Treatment Gel (EPTG) with 0.4% stannous fluoride
Number of subjects: 52
Study 27606566 — intervention group
Group type: COMPARATOR
Intervention: Biotene® Oral Balance Gel (BOBG)
Number of subjects: 52
Study 25608984 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical leek extract cream
Number of subjects: 20
Study 25608984 — intervention group
Group type: COMPARATOR
Intervention: Standard antihemorrhoid cream
Number of subjects: 20
Study 22940055 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 cGy 131-Iodine tositumomab with high-dose BEAM (carmustine, etoposide, cytarabine, and melphalan) followed by autologous stem cell transplantation
Number of subjects: 40
Study 20556439 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubular discectomy
Number of subjects: 216
Study 20556439 — intervention group
Group type: COMPARATOR
Intervention: Conventional microdiscectomy
Number of subjects: 216
Study 20556439 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 216
Study 18358926 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 8 mg/kg
Number of subjects: 623
Study 18358926 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 4 mg/kg
Number of subjects: 623
Study 18358926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 623
Study 16818865 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 101
Study 16818865 — intervention group
Group type: COMPARATOR
Intervention: Community treatment by experts
Number of subjects: 101
Study 14616415 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg once daily)
Number of subjects: 18
Study 14616415 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 18
Study 11506057 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CP) supplementation at 400 microg/day
Number of subjects: 44
Study 11506057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 11506057 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 44
Study 10205417 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Training for Effective Parenting (STEP)
Number of subjects: 18
Study 7531022 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT plus transcatheter hepatic artery infusion chemotherapy (TAI) and embolisation (IAE) treatment (Group B)
Number of subjects: 74
Study 7531022 — intervention group
Group type: COMPARATOR
Intervention: ECT only (Group A)
Number of subjects: 74
Study 7531022 — intervention group
Group type: COMPARATOR
Intervention: ECT plus systemic chemotherapy (Group C)
Number of subjects: 74
Study 3278764 — intervention group
Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (oxerutin; 'Paroven', 'Venoruton', Zyma) 3 g/day
Number of subjects: 40
Study 3278764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30975645 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid (methylprednisolone 40 mg)
Number of subjects: 132
Study 30975645 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 132
Study 28480412 — intervention group
Group type: EXPERIMENTAL
Intervention: liver‐softening medicine plus glucosamine
Number of subjects: 40
Study 28480412 — intervention group
Group type: COMPARATOR
Intervention: glucosamine alone
Number of subjects: 40
Study 25003998 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide coated bioactive stents (BAS)
Number of subjects: 827
Study 25003998 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study 25003998 — intervention group
Group type: COMPARATOR
Intervention: Both BAS and EES
Number of subjects: 827
Study 23993865 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of maintenance medication
Number of subjects: 178
Study 23993865 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation of medication
Number of subjects: 178
Study 21477372 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex education program (video, brochure, individual training by a practice nurse)
Number of subjects: 360
Study 21477372 — intervention group
Group type: COMPARATOR
Intervention: Brochure only (control group)
Number of subjects: 360
Study 21477372 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex education program
Number of subjects: 360
Study 18566802 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-[(11)C]mirtazapine
Number of subjects: 0
Study 18566802 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-[(11)C]mirtazapine
Number of subjects: 0
Study 18566802 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-mirtazapine
Number of subjects: 0
Study 18566802 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-mirtazapine
Number of subjects: 0
Study 16831520 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg estrogen transdermally for 3 days
Number of subjects: 14
Study 16831520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12742438 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-acid modified resin composite/resin composite (PMRC/RC) sandwich restoration
Number of subjects: 29
Study 12742438 — intervention group
Group type: COMPARATOR
Intervention: Direct resin composite (RC) restoration
Number of subjects: 29
Study 10668836 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine therapy
Number of subjects: 825
Study 10668836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study 9059201 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepid bypass (35-36 degrees C)
Number of subjects: 24
Study 9059201 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic bypass (30 degrees C)
Number of subjects: 24
Study 9059201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 29117091 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert demonstrations
Number of subjects: 0
Study 29117091 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice demonstrations
Number of subjects: 0
Study 29117091 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both expert and novice demonstrations
Number of subjects: 0
Study 29117091 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27281726 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural block
Number of subjects: 80
Study 24817827 — intervention group
Group type: EXPERIMENTAL
Intervention: VivaSight™ single lumen endotracheal tube
Number of subjects: 72
Study 24817827 — intervention group
Group type: COMPARATOR
Intervention: Conventional endotracheal tube
Number of subjects: 72
Study 23087249 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC team intervention (experimental unit)
Number of subjects: 82
Study 23087249 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control unit)
Number of subjects: 82
Study 19841767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceram.X/K‐0127
Number of subjects: 43
Study 19841767 — intervention group
Group type: COMPARATOR
Intervention: Tetric Ceram/Syntac Classic
Number of subjects: 43
Study 16783669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion (Group K: n=22)
Number of subjects: 45
Study 16783669 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Group S: n=23)
Number of subjects: 45
Study 15250188 — intervention group
Group type: EXPERIMENTAL
Intervention: Distractor task (completing addition problems)
Number of subjects: 36
Study 15250188 — intervention group
Group type: COMPARATOR
Intervention: Distractor task (viewing addition problems)
Number of subjects: 36
Study 15250188 — intervention group
Group type: COMPARATOR
Intervention: Distractor task (viewing a blank slide)
Number of subjects: 36
Study 15250188 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal (high and low)
Number of subjects: 36
Study 11262503 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based intervention
Number of subjects: 87
Study 11262503 — intervention group
Group type: COMPARATOR
Intervention: Healthy weight management control group
Number of subjects: 87
Study 9040209 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoanal ultrasound performed by two experienced investigators with two different ultrasound machines
Number of subjects: 19
Study 9040209 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoanal ultrasound performed by two investigators independently using a single ultrasound machine in three standardized positions
Number of subjects: 19
Study 7696447 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide enema, 2 mg/100 mL (Entocort)
Number of subjects: 72
Study 7696447 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone acetate foam enema, 125 mg (Colifoam)
Number of subjects: 72
Study 2431838 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (600 mg daily)
Number of subjects: 24
Study 2431838 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprofylline (600 mg daily)
Number of subjects: 24
Study 2431838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31505127 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-load resistance exercise (6 sets at 70% 1-repetition maximum, 90-s rest)
Number of subjects: 11
Study 31505127 — intervention group
Group type: COMPARATOR
Intervention: High-load resistance exercise (6 sets at 90% 1-repetition maximum, 180-s rest)
Number of subjects: 11
Study 31505127 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-load resistance exercise
Number of subjects: 11
Study 31505127 — intervention group
Group type: COMPARATOR
Intervention: High-load resistance exercise
Number of subjects: 11
Study 29939912 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention for chronic disease management
Number of subjects: 302
Study 29939912 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 302
Study 28732741 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting water-stable organosilane (WSO)
Number of subjects: 18
Study 28732741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inert saline solution)
Number of subjects: 18
Study 26710954 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml oral lactulose solution, twice a day for 4 weeks
Number of subjects: 200
Study 26710954 — intervention group
Group type: COMPARATOR
Intervention: Defecation habits training, diet management, and drinking adequate water
Number of subjects: 200
Study 24182675 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 422
Study 21411114 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 63
Study 21411114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 18241718 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal implants
Number of subjects: 62
Study 18241718 — intervention group
Group type: COMPARATOR
Intervention: Placebo procedure
Number of subjects: 62
Study 16483159 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocelectomy with hyperbaric oxygenation (HBO)
Number of subjects: 96
Study 16483159 — intervention group
Group type: COMPARATOR
Intervention: Solitary varicocelectomy
Number of subjects: 96
Study 15096608 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level visual training
Number of subjects: 0
Study 11137070 — intervention group
Group type: EXPERIMENTAL
Intervention: Filshie Clip
Number of subjects: 2126
Study 11137070 — intervention group
Group type: COMPARATOR
Intervention: Hulka Clip
Number of subjects: 2126
Study 9567903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia program
Number of subjects: 28
Study 9567903 — intervention group
Group type: COMPARATOR
Intervention: Text-based information
Number of subjects: 28
Study 8363468 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin/mineral supplement
Number of subjects: 5380
Study 8363468 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin/niacin
Number of subjects: 5380
Study 8363468 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 5380
Study 8363468 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving vitamins)
Number of subjects: 5380
Study 2872809 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin (once daily)
Number of subjects: 174
Study 2872809 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (twice daily)
Number of subjects: 174
Study 2872809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 30907155 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional Shoulder Pain Alignment mobilization protocol
Number of subjects: 20
Study 30907155 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 20
Study 31290251 — intervention group
Group type: EXPERIMENTAL
Intervention: Low walkability areas
Number of subjects: 450
Study 31290251 — intervention group
Group type: COMPARATOR
Intervention: High walkability areas
Number of subjects: 450
Study 28176470 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg (fasted) under unmodified gastric pH
Number of subjects: 26
Study 28176470 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib 250 mg (fasted) 1 hour after ranitidine 450 mg (elevated gastric pH)
Number of subjects: 26
Study 25286883 — intervention group
Group type: EXPERIMENTAL
Intervention: Scissor kicks (SK)
Number of subjects: 12
Study 25286883 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocking (RO)
Number of subjects: 12
Study 25286883 — intervention group
Group type: EXPERIMENTAL
Intervention: Running (RU)
Number of subjects: 12
Study 24479279 — intervention group
Group type: EXPERIMENTAL
Intervention: SureFil SDR flow (SDR)
Number of subjects: 50
Study 24479279 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Silorane (FS)
Number of subjects: 50
Study 24479279 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐aenial Flo bulk fill (GF)
Number of subjects: 50
Study 24479279 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐aenial Universal Flo bulk fill (GUF)
Number of subjects: 50
Study 24479279 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Kalore bulk fill (GK)
Number of subjects: 50
Study 20825806 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 62
Study 20825806 — intervention group
Group type: COMPARATOR
Intervention: Placebo lubricant gel
Number of subjects: 62
Study 19097870 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital psychotherapy (DHP)
Number of subjects: 114
Study 19097870 — intervention group
Group type: COMPARATOR
Intervention: Outpatient individual psychotherapy (OIP)
Number of subjects: 114
Study 16388507 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-1 (PSA cut-off of 4.0 ng/ml and/or abnormal DRE/TRUS)
Number of subjects: 13901
Study 16388507 — intervention group
Group type: COMPARATOR
Intervention: Group-2 (PSA cut-off of 3.0 ng/ml)
Number of subjects: 13901
Study 15288876 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured individualised transfer method
Number of subjects: 162
Study 15288876 — intervention group
Group type: COMPARATOR
Intervention: Existing ad hoc transfer methods
Number of subjects: 162
Study 11368132 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 135
Study 11368132 — intervention group
Group type: COMPARATOR
Intervention: Adding myeloperoxidase (280 ng/ml) to neutrophil granulocyte suspensions
Number of subjects: 135
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Human pial arteries under pressure (60 mm Hg)
Number of subjects: 0
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Human pial arteries at 30 mm Hg
Number of subjects: 0
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Human pial arteries at 60 and 90 mm Hg
Number of subjects: 0
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Human pial arteries contracted to KCl 30 mmol/L, norepinephrine 1 μmol/L, and vasopressin 0.1 μmol/L
Number of subjects: 0
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Human pial arteries relaxed to acetylcholine 3 μmol/L
Number of subjects: 0
Study 9412638 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial distensibility at lower pressures (5 to 50 mm Hg)
Number of subjects: 0
Study 9412638 — intervention group
Group type: COMPARATOR
Intervention: Human omental arteries of comparable size
Number of subjects: 0
Study 8501160 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg MMI daily
Number of subjects: 509
Study 8501160 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg MMI daily
Number of subjects: 509
Study 8501160 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 509
Study 2820202 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre supplement (5 g/day in Study I, 7 g/day in Study II)
Number of subjects: 105
Study 2820202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 2820202 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre supplement
Number of subjects: 105
Study 31005551 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 842
Study 31005551 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypharmacy (≥6 drugs)
Number of subjects: 842
Study 31005551 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable depression
Number of subjects: 842
Study 31005551 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 842
Study 31005551 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, overweight, comorbidity, abnormal C-reactive protein
Number of subjects: 842
Study 28129275 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Daily Undulating Periodization (FDUP)
Number of subjects: 25
Study 28129275 — intervention group
Group type: COMPARATOR
Intervention: Traditional Daily Undulating Periodization (DUP)
Number of subjects: 25
Study 25832541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh red onion meal (100 g providing 156.3 ± 3.4 μmol (47 mg) quercetin)
Number of subjects: 6
Study 25832541 — intervention group
Group type: COMPARATOR
Intervention: Quercetin dihydrate tablet (1800 ± 150 μmol (544 mg) of quercetin)
Number of subjects: 6